| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D | 2024-04-19 | CR Group L.P. | T2 Biosystems, Inc. | 4,104,838 | 46.7% | EDGAR |
| SC 13G | 2024-03-11 | New Dimensions Trading | T2 Biosystems, Inc. | 350,000 | 7.1% | EDGAR |
| SC 13G | 2024-03-11 | Safier Jacob | T2 Biosystems, Inc. | 350,000 | 7.1% | EDGAR |
| SC 13G/A | 2024-02-13 | Lind Global Fund II LP | T2 Biosystems, Inc. | 20,370 | - | EDGAR |
| SC 13G | 2023-07-31 | GSA CAPITAL PARTNERS LLP | T2 Biosystems, Inc. | 4,599,059 | 1.5% | EDGAR |
| SC 13G | 2023-07-13 | CR Group L.P. | T2 Biosystems, Inc. | 72,503,592 | 19.9% | EDGAR |
| SC 13G | 2023-06-30 | GSA CAPITAL PARTNERS LLP | T2 Biosystems, Inc. | 3,799,487 | 15.2% | EDGAR |
| SC 13G | 2023-06-23 | Carrick Jason | T2 Biosystems, Inc. | 2,000,000 | 8.0% | EDGAR |
| SC 13G | 2023-06-22 | Markey John | T2 Biosystems, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2023-06-21 | GSA CAPITAL PARTNERS LLP | T2 Biosystems, Inc. | 24,887,722 | 10.7% | EDGAR |
| SC 13G | 2023-06-16 | Markey John | T2 Biosystems, Inc. | 4,300,000 | 17.3% | EDGAR |
| SC 13G | 2023-06-14 | Markey John | T2 Biosystems, Inc. | 3,650,000 | 14.7% | EDGAR |
| SC 13G | 2023-06-12 | Markey John | T2 Biosystems, Inc. | 2,465,000 | 9.9% | EDGAR |
| SC 13G | 2023-02-21 | Lind Global Fund II LP | T2 Biosystems, Inc. | 1,018,518 | - | EDGAR |
| SC 13G/A | 2021-02-16 | GOLDMAN SACHS & CO. LLC | T2 Biosystems, Inc. | 4,358,868 | 3.0% | EDGAR |
| SC 13G/A | 2020-02-12 | GOLDMAN SACHS GROUP INC | T2 Biosystems, Inc. | 4,324,629 | 9.3% | EDGAR |
| SC 13G/A | 2020-02-07 | Senvest Management, LLC | T2 Biosystems, Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-02-14 | Polaris Venture Partners V, L.P. | T2 Biosystems, Inc. | 1,777,318 | 4.0% | EDGAR |
| SC 13G/A | 2019-02-14 | Lagoda Investment Management, L.P. | T2 Biosystems, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2019-02-14 | TIGER MANAGEMENT L.L.C. | T2 Biosystems, Inc. | 820,499 | 1.9% | EDGAR |